Skip to main content

Alyeska Investment Group, L.P.

Position in ABOS — Acumen Pharmaceuticals, Inc.

CIK 1453072 CHICAGO, IL

Position in ABOS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,554,193
+$760,974 QoQ
Shares Held
2,454,754
0.0% QoQ
Ownership
3.39%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 96 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. ABOS ranks #35 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABOS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,554,193 2,454,754
2026-03-31 $5,793,219 2,454,754
2025-12-31 $1,982,562 939,603
2025-09-30 $1,606,721 939,603
2025-06-30 $1,089,939 939,603
2025-03-31 $1,033,563 939,603
2024-12-31 $1,616,117 939,603
2024-09-30 $2,330,215 939,603
2024-06-30 $2,273,839 939,603
2024-03-31 $3,805,392 939,603
2023-12-31 $2,815,499 733,203
2023-09-30 $2,547,361 613,822